IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $321,746,141 | -18.4% | 20,273,859 | -3.0% | 0.01% | -18.2% |
| Q2 2023 | $394,477,085 | +470.8% | 20,904,986 | +16.2% | 0.01% | +450.0% |
| Q1 2023 | $69,105,904 | -22.7% | 17,996,329 | -0.1% | 0.00% | -33.3% |
| Q4 2022 | $89,359,371 | +7.2% | 18,016,002 | +3.3% | 0.00% | 0.0% |
| Q3 2022 | $83,389,000 | +3.7% | 17,445,026 | -2.4% | 0.00% | 0.0% |
| Q2 2022 | $80,448,000 | +2.8% | 17,877,269 | +8.8% | 0.00% | +50.0% |
| Q1 2022 | $78,225,000 | -29.1% | 16,432,933 | +10.6% | 0.00% | -33.3% |
| Q4 2021 | $110,284,000 | +26.5% | 14,863,304 | -3.4% | 0.00% | +50.0% |
| Q3 2021 | $87,215,000 | -14.2% | 15,381,875 | -0.2% | 0.00% | -33.3% |
| Q2 2021 | $101,596,000 | -23.1% | 15,416,446 | -5.5% | 0.00% | -25.0% |
| Q1 2021 | $132,073,000 | +35.1% | 16,305,586 | +7.6% | 0.00% | +33.3% |
| Q4 2020 | $97,758,000 | +97.7% | 15,156,582 | +10.4% | 0.00% | +50.0% |
| Q3 2020 | $49,438,000 | -25.6% | 13,733,100 | -4.9% | 0.00% | -33.3% |
| Q2 2020 | $66,440,000 | +43.0% | 14,443,396 | +6.0% | 0.00% | +50.0% |
| Q1 2020 | $46,452,000 | -25.3% | 13,621,986 | +11.8% | 0.00% | 0.0% |
| Q4 2019 | $62,190,000 | +112.5% | 12,181,989 | +0.7% | 0.00% | +100.0% |
| Q3 2019 | $29,263,000 | +12.9% | 12,092,437 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $25,922,000 | -22.3% | 11,945,893 | -3.0% | 0.00% | 0.0% |
| Q1 2019 | $33,380,000 | -43.8% | 12,316,896 | -0.5% | 0.00% | -66.7% |
| Q4 2018 | $59,416,000 | -45.4% | 12,378,204 | +7.8% | 0.00% | -40.0% |
| Q3 2018 | $108,733,000 | +7.1% | 11,481,977 | +10.0% | 0.01% | 0.0% |
| Q2 2018 | $101,546,000 | +15.5% | 10,436,350 | +24.9% | 0.01% | +25.0% |
| Q1 2018 | $87,913,000 | +61.9% | 8,356,618 | -1.3% | 0.00% | +33.3% |
| Q4 2017 | $54,294,000 | +29.7% | 8,470,097 | +54.7% | 0.00% | +50.0% |
| Q3 2017 | $41,876,000 | +9.4% | 5,473,981 | +1.7% | 0.00% | 0.0% |
| Q2 2017 | $38,286,000 | +84.3% | 5,384,945 | +0.3% | 0.00% | +100.0% |
| Q1 2017 | $20,774,000 | +129737.5% | 5,368,099 | +70944.2% | 0.00% | – |
| Q4 2016 | $16,000 | -30.4% | 7,556 | -12.9% | 0.00% | – |
| Q3 2016 | $23,000 | -58.2% | 8,672 | -50.8% | 0.00% | – |
| Q2 2016 | $55,000 | +10.0% | 17,633 | +204.1% | 0.00% | – |
| Q1 2016 | $50,000 | +31.6% | 5,798 | +108.0% | 0.00% | – |
| Q4 2015 | $38,000 | +72.7% | 2,788 | +20.2% | 0.00% | – |
| Q3 2015 | $22,000 | -35.3% | 2,320 | 0.0% | 0.00% | – |
| Q2 2015 | $34,000 | +54.5% | 2,320 | -6.1% | 0.00% | – |
| Q1 2015 | $22,000 | +46.7% | 2,471 | 0.0% | 0.00% | – |
| Q4 2014 | $15,000 | -44.4% | 2,471 | 0.0% | 0.00% | – |
| Q3 2014 | $27,000 | -6.9% | 2,471 | 0.0% | 0.00% | – |
| Q2 2014 | $29,000 | -29.3% | 2,471 | -9.3% | 0.00% | – |
| Q1 2014 | $41,000 | +2.5% | 2,724 | 0.0% | 0.00% | – |
| Q4 2013 | $40,000 | -13.0% | 2,724 | 0.0% | 0.00% | – |
| Q3 2013 | $46,000 | +2.2% | 2,724 | 0.0% | 0.00% | – |
| Q2 2013 | $45,000 | – | 2,724 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |